Community Medicine (PSM) · Communicable Diseases (Malaria, Tuberculosis, Dengue, Polio, Hepatitis, Cholera)

Under the National Vector Borne Disease Control Programme, a patient with microscopy-confirmed Plasmodium vivax malaria has completed chloroquine therapy. What radical treatment should be added to prevent relapse?

  • A Primaquine 0.25 mg/kg body weight daily for 14 days
  • B Primaquine 0.75 mg/kg body weight as a single dose
  • C Primaquine 0.5 mg/kg body weight daily for 7 days
  • D Artesunate plus sulfadoxine-pyrimethamine for 3 days
Correct answer: A. Primaquine 0.25 mg/kg body weight daily for 14 days

Explanation

P. vivax forms hypnozoites in the liver that cause relapse, so radical cure requires primaquine 0.25 mg/kg daily for 14 days after chloroquine. The 0.75 mg/kg single dose is the gametocytocide dose used in P. falciparum to block transmission, it does not clear hypnozoites. G6PD deficiency must be checked before giving the full 14-day course.

Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Communicable Diseases (Malaria, Tuberculosis, Dengue, Polio, Hepatitis, Cholera) MCQs

See all Communicable Diseases (Malaria, Tuberculosis, Dengue, Polio, Hepatitis, Cholera) MCQs →